MedTrace Logo

Fluvastatin Versus Hepatitis C Virus

NCT00441493 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2012-07-27

No results posted yet for this study

Summary

This is a dose finding and efficacy trial for fluvastatin versus hepatitis C.

Conditions

  • Hepatitis C

Interventions

DRUG

fluvastatin

Sponsors & Collaborators

Principal Investigators

  • Ted Bader, MD · VA Medical Center and University of Oklahoma

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2007-03-31
Completion
2007-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00441493 on ClinicalTrials.gov